These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31988293)

  • 1. Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus.
    Lopeman RC; Harrison J; Rathbone DL; Desai M; Lambert PA; Cox JAG
    Sci Rep; 2020 Jan; 10(1):928. PubMed ID: 31988293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of relebactam-mediated inhibition of Mycobacterium abscessus BlaMab β-lactamase on the in vitro and intracellular efficacy of imipenem.
    Le Run E; Atze H; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2020 Feb; 75(2):379-383. PubMed ID: 31637424
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kaushik A; Ammerman NC; Lee J; Martins O; Kreiswirth BN; Lamichhane G; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors.
    Dousa KM; Kurz SG; Taracila MA; Bonfield T; Bethel CR; Barnes MD; Selvaraju S; Abdelhamed AM; Kreiswirth BN; Boom WH; Kasperbauer SH; Daley CL; Bonomo RA
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393499
    [No Abstract]   [Full Text] [Related]  

  • 5. β-Lactamase inhibition by avibactam in Mycobacterium abscessus.
    Dubée V; Bernut A; Cortes M; Lesne T; Dorchene D; Lefebvre AL; Hugonnet JE; Gutmann L; Mainardi JL; Herrmann JL; Gaillard JL; Kremer L; Arthur M
    J Antimicrob Chemother; 2015 Apr; 70(4):1051-8. PubMed ID: 25525201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the β-Lactamase Bla
    Lefebvre AL; Le Moigne V; Bernut A; Veckerlé C; Compain F; Herrmann JL; Kremer L; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096155
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
    Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
    mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The addition of avibactam renders piperacillin an effective treatment for
    Meir M; Bifani P; Barkan D
    Antimicrob Resist Infect Control; 2018; 7():151. PubMed ID: 30564307
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745387
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of diazabicyclooctane β-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex.
    Misawa K; Nishimura T; Kashimura S; Enoki Y; Taguchi K; Uno S; Uwamino Y; Matsumoto K; Hasegawa N
    Int J Antimicrob Agents; 2022; 60(5-6):106669. PubMed ID: 36064079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The
    Fröberg G; Ahmed A; Chryssanthou E; Davies Forsman L
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0052823. PubMed ID: 37671880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
    Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
    J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the
    Kaushik A; Ammerman NC; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex
    Pandey R; Chen L; Manca C; Jenkins S; Glaser L; Vinnard C; Stone G; Lee J; Mathema B; Nuermberger EL; Bonomo RA; Kreiswirth BN
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus.
    Lefebvre AL; Dubée V; Cortes M; Dorchêne D; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2016 Jun; 71(6):1556-63. PubMed ID: 26929268
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Chen L; Shashkina E; Kurepina N; Calado Nogueira de Moura V; Daley CL; Kreiswirth BN
    Antimicrob Agents Chemother; 2024 May; 68(5):e0017424. PubMed ID: 38557171
    [No Abstract]   [Full Text] [Related]  

  • 18. Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
    Kaushik A; Gupta C; Fisher S; Story-Roller E; Galanis C; Parrish N; Lamichhane G
    Future Microbiol; 2017 May; 12(6):473-480. PubMed ID: 28326811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease.
    Pozuelo Torres M; van Ingen J
    Clin Microbiol Infect; 2024 Jun; 30(6):738-742. PubMed ID: 38527611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae.
    Papp-Wallace KM; Barnes MD; Alsop J; Taracila MA; Bethel CR; Becka SA; van Duin D; Kreiswirth BN; Kaye KS; Bonomo RA
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.